About the MIT Program
Saint Louis University's Master of Science (M.S.) in Molecular Imaging and Therapeutics program is for students with a background in imaging or radiologic science who want to pursue a new area of study for educational and research
This degree is a 12-month, three semester program with a rigorous curriculum. This degree option combines a collaborative research component with individual areas of imaging and therapeutic sciences.
Students choose to study one of the following:
- Magnetic Resonance Imaging
- Nuclear Medicine Technology
- Radiation Therapy
The program includes a required Masters Seminar course each semester which will contain an advanced scholarly component designed to enhance the content of other courses in their chosen area of study. The Masters Seminar courses are completed under the direction of a scholarly mentor and will result in a scholarly project suitable for publication in a peer reviewed journal, professional presentation, or scholarly equivalent by program completion.
By the end of graduate program, the student will be required to have completed all graduate course credit, including all scholarly projects presented. The professional graduate student will be expected to integrate the knowledge of both chosen medical imaging majors into their project, possibly producing ground-breaking research not previously explored or published and suitable for journal publication.
Students must maintain a cumulative GPA of 3.0 on a 4.0 scale in all required graduate professional courses.
Background of the program
- Personalized medicine is a medical model emphasizing the systematic use of information about an individual patient to select or optimize the patient's preventative and therapeutic care. It can be broadly defined as products and services that leverage the science of genomics (discipline in genetics) and proteomics (large scale studies of proteins) and capitalize on the trends of wellness and consumerism to enable tailored approaches to prevention and care.
- Over the past century, medical care has centered on standards of care based on epidemiological studies of large cohorts. However, large cohorts do not take into account genetic variability of individuals within a population. Advances in the molecular sciences are offering new paradigms for diagnosing and treating disease.
- Molecular imaging emerged in the early 21st century as a discipline at the intersection of molecular biology and in vivo imaging. Molecular imaging differs from traditional imaging in that probes known as biomarkers are used to help image particular targets or pathways.
- Biomarkers interact chemically with their surroundings and in turn alter the image according to molecular changes occurring within the area of interest. The process is markedly different from previous methods of imaging which primarily imaged differences in qualities such as density or water content.
- The ability to image fine molecular changes opens up an incredible number of possibilities for medical applications, including early detection and treatment of disease and basic pharmaceutical development. The multiple and numerous potentials of this field are applicable to the diagnosis of diseases such as cancer, neurological disorders, and cardiovascular diseases.